90 related articles for article (PubMed ID: 21351482)
41. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling.
Hung JH; Lu YS; Wang YC; Ma YH; Wang DS; Kulp SK; Muthusamy N; Byrd JC; Cheng AL; Chen CS
Cancer Res; 2008 Feb; 68(4):1204-12. PubMed ID: 18281497
[TBL] [Abstract][Full Text] [Related]
42. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
[TBL] [Abstract][Full Text] [Related]
43. Potential therapeutic effects of curcumin mediated by JAK/STAT signaling pathway: A review.
Ashrafizadeh M; Rafiei H; Mohammadinejad R; Afshar EG; Farkhondeh T; Samarghandian S
Phytother Res; 2020 Aug; 34(8):1745-1760. PubMed ID: 32157749
[TBL] [Abstract][Full Text] [Related]
44. Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells.
Zhao LJ; Hua X; He SF; Ren H; Qi ZT
Virol J; 2011 Apr; 8():157. PubMed ID: 21466707
[TBL] [Abstract][Full Text] [Related]
45. Protective effect of curcumin on TNBS-induced intestinal inflammation is mediated through the JAK/STAT pathway.
Zhang X; Wu J; Ye B; Wang Q; Xie X; Shen H
BMC Complement Altern Med; 2016 Aug; 16(1):299. PubMed ID: 27544348
[TBL] [Abstract][Full Text] [Related]
46. Effect of curcumin on the proliferation, apoptosis, migration, and invasion of human melanoma A375 cells.
Zhang YP; Li YQ; Lv YT; Wang JM
Genet Mol Res; 2015 Feb; 14(1):1056-67. PubMed ID: 25730045
[TBL] [Abstract][Full Text] [Related]
47. Impact of curcumin on p38 MAPK: therapeutic implications.
Shamsnia HS; Roustaei M; Ahmadvand D; Butler AE; Amirlou D; Soltani S; Momtaz S; Jamialahmadi T; Abdolghaffari AH; Sahebkar A
Inflammopharmacology; 2023 Oct; 31(5):2201-2212. PubMed ID: 37498375
[TBL] [Abstract][Full Text] [Related]
48. Monoterpene (-)-citronellal affects hepatocarcinoma cell signaling via an olfactory receptor.
Maßberg D; Simon A; Häussinger D; Keitel V; Gisselmann G; Conrad H; Hatt H
Arch Biochem Biophys; 2015 Jan; 566():100-9. PubMed ID: 25513961
[TBL] [Abstract][Full Text] [Related]
49. Curcumin prevents osteocyte apoptosis by inhibiting M1-type macrophage polarization in mice model of glucocorticoid-associated osteonecrosis of the femoral head.
Jin S; Meng C; He Y; Wang X; Zhang Q; Wang Z; Huang W; Wang H
J Orthop Res; 2020 Sep; 38(9):2020-2030. PubMed ID: 32009245
[TBL] [Abstract][Full Text] [Related]
50. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
51. HO-3867, a curcumin analog, elicits cell apoptosis and p38-mediated caspase activation in hepatocellular carcinoma.
Hsueh KC; Ju PC; Hsieh YH; Su SC; Yeh CB; Lin CW
Environ Toxicol; 2024 Feb; 39(2):794-802. PubMed ID: 37782689
[TBL] [Abstract][Full Text] [Related]
52. Anti-Cancer Activity of Curcumin on Multiple Myeloma.
Mirzaei H; Bagheri H; Ghasemi F; Khoi JM; Pourhanifeh MH; Heyden YV; Mortezapour E; Nikdasti A; Jeandet P; Khan H; Sahebkar A
Anticancer Agents Med Chem; 2021; 21(5):575-586. PubMed ID: 32951583
[TBL] [Abstract][Full Text] [Related]
53. Curcumin Therapeutic Modulation of the Wnt Signaling Pathway.
Ashrafizadeh M; Ahmadi Z; Mohamamdinejad R; Yaribeygi H; Serban MC; Orafai HM; Sahebkar A
Curr Pharm Biotechnol; 2020; 21(11):1006-1015. PubMed ID: 32133961
[TBL] [Abstract][Full Text] [Related]
54. Curcumin Treatment in Combination with Glucose Restriction Inhibits Intracellular Alkalinization and Tumor Growth in Hepatoma Cells.
Kim SW; Cha MJ; Lee SK; Song BW; Jin X; Lee JM; Park JH; Lee JD
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091659
[TBL] [Abstract][Full Text] [Related]
55. Curcuminoid-phospholipid complex induces apoptosis in mammary epithelial cells by STAT-3 signaling.
Starvaggi Cucuzza L; Motta M; Miretti S; Accornero P; Baratta M
Exp Mol Med; 2008 Dec; 40(6):647-57. PubMed ID: 19116450
[TBL] [Abstract][Full Text] [Related]
56. Curcumin: a promising agent targeting cancer stem cells.
Zang S; Liu T; Shi J; Qiao L
Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
[TBL] [Abstract][Full Text] [Related]
57. Lestaurtinib's antineoplastic activity converges on JAK/STAT signaling to inhibit advanced forms of therapy resistant ovarian cancer.
Rodman EPB; Emch MJ; Hou X; Bajaj A; Pearson NA; John AJ; Ortiz Y; Bass AD; Singh S; Baldassarre G; Kaufmann SH; Weroha SJ; Hawse JR
bioRxiv; 2024 Jun; ():. PubMed ID: 38895264
[TBL] [Abstract][Full Text] [Related]
58. Curcumin as tyrosine kinase inhibitor in cancer treatment.
Golonko A; Lewandowska H; Świsłocka R; Jasińska UT; Priebe W; Lewandowski W
Eur J Med Chem; 2019 Nov; 181():111512. PubMed ID: 31404861
[TBL] [Abstract][Full Text] [Related]
59. Turmeric: a spice for life?
Balachandran K; Stebbing J
Lancet Oncol; 2016 Dec; 17(12):1639. PubMed ID: 27924745
[No Abstract] [Full Text] [Related]
60. Comparative Transcriptomic Analysis of Three Common Liver Cell Lines.
Arzumanian V; Pyatnitskiy M; Poverennaya E
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
